VOR

Conviction 69HealthcareScan · Thu, Jun 25, 2026

VOR$14.96+3.28%

ResistanceSupportVol 14Insider sell

Vol MA14 1.25M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Vor Biopharma Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.vorbio.com ↗

Price14.96

Change+3.28%

Gap+0.48%

Rel volume3.54×

Avg volume1.06M

Avg $ vol15.2M

SMA 2014.20

SMA 5014.76

SMA 20016.14

Price vs 50+1.34%

Price vs 200-7.34%

MA stackmixed

50/200 cross—

Supertrenddown · 16.03

RSI (14)54

MACD hist0.15

MACD crossbull · 7d

Stoch %K / %D82 / 76

ADX (14)12

+DI / −DI25 / 17

RSI divergence—

MACD divergence—

ATR %+6.51%

ADR %6.47%

52w high48.72

52w low0.5544

From 52w high-69.30%

Above 52w low+2597.51%

New 52w highNo

SqueezeOff

Bollinger width18.79%

%B0.78

Donchian pos82.18%

Donchian high15.47

Donchian low12.58

AVWAP (52w high)14.26

vs AVWAP high+4.86%

AVWAP (52w low)3.80

vs AVWAP low+293.82%

OBV trendFlat

Chaikin MF (20)-0.16

Today vs 20d3.54×

Avg vol (14d)1.25M

Avg vol (20d)1.06M

Avg $ vol (20d)15.2M

Market cap810.35M

RS 3m (vs SPY)+6.92%

RS 6m (vs SPY)+8.94%

RS line new highNo

Trend template4/8

Technical rank48.2

1 week-0.43%

1 month+6.06%

3 months+15.57%

6 months+9.08%

1 year+4601.35%

YTD+28.48%

P/E-1.16

P/B-5.39

P/S—

P/FCF-5.64

EPS-70.50

Div yield—

ROE462.68%

ROA-137.34%

Debt/Eq—

Current31.15

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-495.29%

Price target33.80

Target upside126.01%

Analyst ratingBuy

Institutional76.07%

Ent. value640.48M

Revenue—

Net income-219.59M

Gross profit—

Free cash flow-143.65M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out54.19M

Employees76

ListedFri, Feb 5, 2021

Free float29.19M

Float %70.3%

Short interest4.82M

Days to cover6.0d

Short volume59.7%

Squeeze score86 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.73 vs −$0.75

Last surprise+2.7% beat

Setup gradeB

Conviction69 / 100

Pattern quality—

Tech rank48.2 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance16.94

Support13.12

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VOR

All disclosures →

No recent disclosed trades by Congress in VOR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VOR · 10 sells

Insider	Side	Shares	Value	Traded	Filed
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-04-22	Sell	165.15K	$2.6M	2026-04-22	2026-04-24
RA Capital Healthcare Fund LP Director · Common Stock · 2026-04-22	Sell	165.15K	$2.6M	2026-04-22	2026-04-24
Kolchinsky Peter Director · Common Stock · 2026-04-22	Sell	165.15K	$2.6M	2026-04-22	2026-04-24
Shah Rajeev M. Director · Common Stock · 2026-04-22	Sell	165.15K	$2.6M	2026-04-22	2026-04-24
Kolchinsky Peter Director · Common Stock · 2026-04-20	Sell	171.96K	$2.7M	2026-04-20	2026-04-21
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-04-20	Sell	171.96K	$2.7M	2026-04-20	2026-04-21
RA Capital Healthcare Fund LP Director · Common Stock · 2026-04-20	Sell	171.96K	$2.7M	2026-04-20	2026-04-21
Shah Rajeev M. Director · Common Stock · 2026-04-20	Sell	171.96K	$2.7M	2026-04-20	2026-04-21
Kolchinsky Peter Director · Common Stock · 2026-04-17	Sell	458.41K	$7.5M	2026-04-17	2026-04-21
Shah Rajeev M. Director · Common Stock · 2026-04-17	Sell	458.41K	$7.5M	2026-04-17	2026-04-21

SEC filings

EDGAR filings in VOR · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.